All blog items

Register now for School of Medicine Financial Boot Camp

Registration is now open for the next School of Medicine Financial Boot Camp – a multi-part series designed to help faculty understand core finance issues with a focus on medical school economics.  Sessions will be led by Executive Vice Dean Scott Gibson. Participants will be introduced to core financial concepts such as the present value of money, rate of return, basic funds flow modeling for investment decisions, and evaluating the bottom line of investments.   

Obesity Can Add Five Weeks of Asthma Symptoms Per Year in Preschoolers

  Inhalers work for all preschoolers, but less beneficial for those who stay heavy as they age Asthma affects almost 1 in 10 children in the U.S. and is a leading cause of emergency room visits and hospitalizations in preschoolers. According to new research from Duke Health and collaborators, symptoms may be worse for children ages 2 to 5 who are overweight.

Stimulating Heart Muscle to Regrow After Injury

[Video:https://youtu.be/LNib9sdX_Jc] Scientists, engineers and clinicians are working together at Duke University's Renegeration Next Initiative to learn how human tissue might be repaired and replaced, using the body's own innate biology. For now, a living, beating patch of heart muscle in a dish is a promising step forward. 

Dr. Thomas Owens Named President of Duke University Hospital

DURHAM, N.C. -- Thomas A. Owens, M.D. has been named president of Duke University Hospital, effective Jan. 1, 2018. Owens succeeds Kevin Sowers, who leaves Duke early next year to become president of the Johns Hopkins Health System and executive vice president of Johns Hopkins Medicine. [Video:https://youtu.be/2YI8MJhcZWw]

Lyme Study Uses Drug Discovery Methods That Have Fueled Cancer Breakthroughs

Labs at Duke and other academic centers collaborate to identify alternatives to antibiotics Antibiotics are currently the only treatments available for Lyme disease and other tick-borne illnesses, but researchers at Duke Health are working to expand the medical toolkit by identifying vulnerable areas of disease-causing bacteria that could lead to innovative therapies.

Existing Cancer Medication Offers Potential to Treat Huntington’s Disease

A drug already used to treat certain forms of cancer may also be an effective therapy for Huntington’s disease, according to a new study in the latest issue of Science Translational Medicine. The same study also increases our understanding of how this drug, and other medications like it, may offer hope for other neurodegenerative diseases like Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease.